Tuberculosis, or TB, is an infectious disease that is treated with antibiotics. But some bacteria have found ways to resist or fight off antibiotics due to incorrectly administered treatment. When the two main antibiotics stop being effective against the disease, it is labelled multi-drug resistant tuberculosis, or MDR-TB.
MDR-TB is deadly and it's a major public health issue, but for the past 50 years it has largely been ignored. Now, the needs of patients suffering from tuberculosis are finally being addressed, and patients with MDR-TB can hope to have access to effective treatments within the next few years.